These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33752610)

  • 21. Real-world experience with Curcumin-QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study.
    Yanai H; Salomon N; Lahat A; Ungar B; Eliakim R; Kriger-Sharabi O; Reiss-Mintz H; Koslowsky B; Shitrit AB; Tamir-Degabli N; Dotan I; Zittan E; Maharshak N; Hirsch A; Ben-Horin S; Kopylov U
    Aliment Pharmacol Ther; 2023 Jul; 58(2):175-181. PubMed ID: 37157131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform.
    Mangia M; Giuffrida E; Figini V; Colombo A; Carli E; Lavagna A; Mendolaro M; Morello E; Cosimato M; Rocca R; Pagana G; Daperno M
    Scand J Gastroenterol; 2023 Mar; 58(3):240-247. PubMed ID: 36148538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis.
    Ankersen DV; Weimers P; Marker D; Johannesen T; Iversen S; Lilje B; Kristoffersen AB; Saboori S; Paridaens K; Skytt Andersen P; Burisch J; Munkholm P
    Scand J Gastroenterol; 2020 Nov; 55(11):1291-1300. PubMed ID: 33045169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary Calprotectin Is not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease.
    Bos V; Crouwel F; Waaijenberg P; Bouma G; Duijvestein M; Buiter HJ; Brand HS; Hamer HM; De Boer NK
    J Gastrointestin Liver Dis; 2022 Sep; 31(3):283-289. PubMed ID: 36004414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessing the Correlation of Fecal Calprotectin and the Clinical Disease Activity Index in Patients With Ulcerative Colitis.
    Amiriani T; Besharat S; Dadjou M; Roshandel G; Mirkarimi H; Salamat F; Joshaghani H
    Gastroenterol Nurs; 2018; 41(3):201-205. PubMed ID: 29847394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing disease activity indices in ulcerative colitis.
    Walsh AJ; Ghosh A; Brain AO; Buchel O; Burger D; Thomas S; White L; Collins GS; Keshav S; Travis SP
    J Crohns Colitis; 2014 Apr; 8(4):318-25. PubMed ID: 24120021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining relapse of ulcerative colitis using a symptom-based activity index.
    Jowett SL; Seal CJ; Phillips E; Gregory W; Barton JR; Welfare MR
    Scand J Gastroenterol; 2003 Feb; 38(2):164-71. PubMed ID: 12678333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis.
    Taghvaei T; Maleki I; Nagshvar F; Fakheri H; Hosseini V; Valizadeh SM; Neishaboori H
    Intern Emerg Med; 2015 Apr; 10(3):321-8. PubMed ID: 25366383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis.
    Marcovitch L; Focht G; Carmon N; Tersigni C; Ledder O; Lev-Tzion R; Church PC; Hyams JS; Baldassano RN; Bousvaros A; Mack DR; Hussey S; Otley A; Croft NM; Kappelman MD; Griffiths AM; Turner D
    Gastroenterology; 2023 Apr; 164(4):610-618.e4. PubMed ID: 36539016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
    Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does colonoscopy cause increased ulcerative colitis symptoms?
    Menees S; Higgins P; Korsnes S; Elta G
    Inflamm Bowel Dis; 2007 Jan; 13(1):12-8. PubMed ID: 17206634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms.
    Wilson B; Eyice Ö; Koumoutsos I; Lomer MC; Irving PM; Lindsay JO; Whelan K
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps.
    Bermejo F; Algaba A; Bonillo D; Jiménez L; Guardiola-Arévalo A; Pacheco M; Castaño Á; Guerra I
    Gastroenterol Hepatol; 2020 Feb; 43(2):73-78. PubMed ID: 31648810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.
    Lasson A; Stotzer PO; Öhman L; Isaksson S; Sapnara M; Strid H
    J Crohns Colitis; 2015 Jan; 9(1):26-32. PubMed ID: 25008478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis.
    Hosoe N; Nakano M; Takeuchi K; Endo Y; Matsuoka K; Abe T; Omori T; Hayashida M; Kobayashi T; Yoshida A; Mizuno S; Nakazato Y; Naganuma M; Kanai T; Watanabe M; Ueno F; Suzuki Y; Hibi T; Ogata H
    Inflamm Bowel Dis; 2018 Nov; 24(12):2641-2647. PubMed ID: 29846579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.